NCT07112911 Effects of Combined Neuromuscular Electrical Stimulation Robot and Trans-Spinal Electrical Stimulation in Poststroke Rehabilitation
| NCT ID | NCT07112911 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Hong Kong Polytechnic University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 65 participants |
| Start Date | 2025-07-28 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 65 participants in total. It began in 2025-07-28 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to investigate the clinical efficacy and neurological progress of combined training using trans-spinal electrical stimulation (tsES) and neuromuscular electrical stimulation (NMES)-driven robotics on upper limb rehabilitation after stroke
Eligibility Criteria
Inclusion Criteria: * Subjects in the chronic stage (start from 6 months after the onset of stroke) with a pure unilateral motor paresis after a stroke (ischemic or hemorrhagic); * Sufficient cognition to follow simple instructions as well as understand the content and purpose of the experiment (Mini-Mental State Examination (MMSE) score\>23); * Be able to sit up for 60 minutes (with or without assistance); * Muscle strength graded from 1 to 3 in biceps brachii, triceps brachii, extensor carpi radialis, flexor carpi radialis, and abductor pollicis brevis in the affected side. * The voluntary electromyographic signals of the wrist extensor and wrist flexor muscle groups can be detected. Exclusion Criteria: * Patients with secondary stroke; * Severe dysphasia (either expressive or comprehensive) with inadequate communication; * Any additional medical or psychological condition affecting their ability to comply with the study protocol; * History of other neurological disease, psychiatric disorder, including alcoholism and substance abuse; * currently pregnant; * epilepsy; * pacemaker implantation or deep brain stimulation; * involved in drug studies, other clinical trials, or concurrent medication/occupational/physical treatments on the upper limb; * skin disease at the area of the electrodes; * High hypertension and cannot maintain normal blood pressure despite daily intake of antihypertensive medication.
Contact & Investigator
Xiaoling HU
PRINCIPAL INVESTIGATOR
The Hong Kong Polyterchnic University
Frequently Asked Questions
Who can join the NCT07112911 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, up to 70 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07112911 currently recruiting?
Yes, NCT07112911 is actively recruiting participants. Visit ClinicalTrials.gov or contact The Hong Kong Polytechnic University to inquire about joining.
Where is the NCT07112911 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong, Hong Kong, Hong Kong.
Who is sponsoring the NCT07112911 clinical trial?
NCT07112911 is sponsored by The Hong Kong Polytechnic University. The principal investigator is Xiaoling HU at The Hong Kong Polyterchnic University. The trial plans to enroll 65 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.